Skip to content

New leadership to enhance healthcare in rural Australia

By API User

The National Rural Health Alliance (the Alliance) is excited to announce the appointment of a new Chairperson and Board Members who will guide the organisation towards improved healthcare outcomes for rural communities across Australia.   Heather Keighley, a Lecturer at Flinders University College of Medicine and Public Health in Darwin and a Board member of … Continued

Stroke associated with long-term cognitive decline

By API User

UNDER EMBARGO: 2 October 11am US Eastern time | 3 October 1am Sydney AEST time  New evidence from the Centre for Healthy Brain Ageing (CHeBA) indicates that older adults who experience a stroke for the first time will have substantial immediate and accelerated long term-cognitive decline.  Stroke is a leading cause of disability and dementia … Continued

Welcome funding to care for the rural ageing population

By API User

The Federal Government’s announcement of a $900 million investment to enhance aged care services in rural and remote areas is a vital step towards ensuring that older Australians, regardless of their postcode, can access the high-quality, safe aged care they deserve.   “We know that older people living in rural, regional and remote Australia face … Continued

$1.46 million secured to innovate a reduction in wait times

By API User

•    Eastern Health Professor of Allied Health and Implementation Science, Katherine Harding is finding innovative ways to improve timely specialist care, after successfully securing $1.46 million as part of the National Health and Medical Research Council (NHMRC) Partnership Project scheme. •    The WaitLESS project will trial the Specific Timely Assessment Triage (STAT) model … Continued

Breakthrough in the hunt for broad-spectrum malaria therapy

By API User

Scientists at La Trobe University have discovered a new antibody-like molecule which could be used in therapy to prevent infection from multiple malaria parasite species.   The research, recently published in Nature Communications, found that when the molecule WD34 binds with a protein produced by malaria parasites, it inhibits their ability to infect cells at different … Continued

Cabometyx® (Cabozantinib) now available for eligible patients with non-clear cell renal cell carcinoma via the PBS

By API User

  SEPTEMBER 1 2024: Cabometyx® (Cabozantinib), a once-daily oral medication, is now available on the Pharmaceutical Benefits Scheme (PBS) for eligible patients with Stage IV non-clear cell renal cell carcinoma. Previously, patients living with Stage IV non-clear cell renal cell carcinoma had no PBS-reimbursed treatment option.2   Cabometyx® is a tyrosine kinase inhibitor (TKI) that … Continued

NeuRA launches world’s largest clinical trial for phantom limb pain

By API User

Key points NeuRA is now recruiting for TITAN, the world’s largest clinical trial to date into potential treatments phantom limb pain.   Phantom limb pain is a condition that baffles scientists and affects up to 80% of people who have undergone limb amputation. The trial will investigate the effectiveness of two drug-free treatments that aim to provide … Continued